Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial

Rutkowski, P.; Gaston, L.; Borkowska, A.; Stacchiotti, S.; Gelderblom, H.; Baldi, G.G.; ... ; Grimer, R. (2018)

Article / Letter to editor

• Denosumab
• RANKL
• Giant cell tumor of bone
• Neoadjuvant therapy

• All authors: Rutkowski, P.; Gaston, L.; Borkowska, A.; Stacchiotti, S.; Gelderblom, H.; Baldi, G.G.; Palmerini, E.; Casali, P.; Gronchi, A.; Parry, M.; Campanacci, D.A.; Scoccianti, G.; Wagrodzki, M.; Ferrari, S.; Dijkstra, S.; Pienkowski, A.; Grimer, R.
• Date: 2018-09-30
• Journal: EJSO - European Journal of Surgical Oncology
• Volume: 44
• Issue: 9
• Pages: 1384 - 1390
• DOI: doi:10.1016/j.ejso.2018.03.020